188 related articles for article (PubMed ID: 34958011)
1. Predicting malignancy in thyroid nodules with benign cytology results: The role of Conventional Ultrasound, Shear Wave Elastography and BRAF V600E.
Zhang Y; Lu F; Shi H; Guo LH; Wei Q; Xu HX; Zhang YF
Clin Hemorheol Microcirc; 2022; 81(1):33-45. PubMed ID: 34958011
[TBL] [Abstract][Full Text] [Related]
2. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
Nam SY; Han BK; Ko EY; Kang SS; Hahn SY; Hwang JY; Nam MY; Kim JW; Chung JH; Oh YL; Shin JH
Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782
[TBL] [Abstract][Full Text] [Related]
3. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
Kim SY; Kim EK; Kwak JY; Moon HJ; Yoon JH
Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
[TBL] [Abstract][Full Text] [Related]
4. Is follow-up BRAF(V600E) mutation analysis helpful in the differential diagnosis of thyroid nodules with negative results on initial analysis?
Yoon JH; Kim EK; Moon HJ; Kwak JY
PLoS One; 2013; 8(3):e58592. PubMed ID: 23505540
[TBL] [Abstract][Full Text] [Related]
5. Comparison of diagnostic value of SWE, FNA and BRAF gene detection in ACR TI-RADS 4 and 5 thyroid nodules.
Zhang WB; Deng WF; Mao L; He BL; Liu H; Chen J; Liu Y; Qi TY
Clin Hemorheol Microcirc; 2022; 81(1):13-21. PubMed ID: 35068450
[TBL] [Abstract][Full Text] [Related]
6. Value of
Chen X; Zhou Q; Wang F; Zhang F; Du H; Zhang Q; Wu W; Gong X
AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
[TBL] [Abstract][Full Text] [Related]
7. Additional BRAF mutation analysis may have additional diagnostic value in thyroid nodules with "suspicious for malignant" cytology alone even when the nodules do not show suspicious US features.
Seo JY; Kim EK; Kwak JY
Endocrine; 2014 Sep; 47(1):283-9. PubMed ID: 24452872
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration.
Moon HJ; Kim EK; Chung WY; Choi JR; Yoon JH; Kwak JY
Ann Surg Oncol; 2011 Mar; 18(3):792-9. PubMed ID: 20945104
[TBL] [Abstract][Full Text] [Related]
9. The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.
Lee EJ; Song KH; Kim DL; Jang YM; Hwang TS; Kim SK
Clin Endocrinol (Oxf); 2011 Dec; 75(6):844-50. PubMed ID: 21707687
[TBL] [Abstract][Full Text] [Related]
10. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
Kwon HJ; Kim EK; Kwak JY
Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of shear-wave ultrasound elastography in thyroid nodules: diagnostic performance for predicting malignancy.
Kim H; Kim JA; Son EJ; Youk JH
Eur Radiol; 2013 Sep; 23(9):2532-7. PubMed ID: 23604801
[TBL] [Abstract][Full Text] [Related]
12. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF
Lin Y; Luo YK; Li J; Ren XY; Wang HW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
[TBL] [Abstract][Full Text] [Related]
14. BRAF
Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China.
Lan Z; Yang F; Zhang J; Lan Y; Li H; He R
Acta Cytol; 2023; 67(6):629-638. PubMed ID: 37708867
[TBL] [Abstract][Full Text] [Related]
16. The values of shear wave elastography in avoiding repeat fine-needle aspiration for thyroid nodules with nondiagnostic and undetermined cytology.
Chen L; Shi YX; Liu YC; Zhan J; Diao XH; Chen Y; Zhan WW
Clin Endocrinol (Oxf); 2019 Jul; 91(1):201-208. PubMed ID: 31004514
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
Yoo EY; Shin JH; Ko EY; Han BK
AJR Am J Roentgenol; 2012 Apr; 198(4):891-5. PubMed ID: 22451557
[TBL] [Abstract][Full Text] [Related]
18. BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.
Sheng D; Yu X; Li H; Zhang M; Chen J
Medicine (Baltimore); 2021 Sep; 100(37):e27167. PubMed ID: 34664843
[TBL] [Abstract][Full Text] [Related]
19. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
Trimboli P; Scappaticcio L; Treglia G; Guidobaldi L; Bongiovanni M; Giovanella L
Endocr Pathol; 2020 Mar; 31(1):57-66. PubMed ID: 31811566
[TBL] [Abstract][Full Text] [Related]
20. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
Marchetti I; Lessi F; Mazzanti CM; Bertacca G; Elisei R; Coscio GD; Pinchera A; Bevilacqua G
Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
